Health In Tech, Inc.

Health In Tech maintains a conservative capital structure with zero debt-to-equity and a current ratio of 3.13, supported by $10.3 million in cash and equivalents against $7.4 million in total liabilities. The company holds $21.6 million in total equity, providing a strong liquidity buffer despite negative operating cash flow of $3.3 million in Q1 2026. The absence of debt eliminates interest coverage risk, while the high current ratio indicates ample short-term asset coverage for liabilities.

Profitability remains negative with a net loss of $1.6 million in Q1 2026, resulting in a negative return on equity of -0.0592 and return on assets of -0.0441. The company trades at a price-to-book multiple of 2.48 and an EV-to-revenue multiple of 1.3, reflecting market skepticism toward current earnings generation. Gross profit of $4.5 million on $8.8 million in revenue indicates a gross margin of approximately 51%, suggesting underlying operational efficiency before operating expenses and stock-based compensation drag on net income.

Health In Tech, Inc. (HIT) has recorded two notable additions to its shareholder base, marking the first analysis for the ticker with no prior basis for delta computation. These changes involve new institutional investors acquiring positions as of March 31, 2026, signaling early accumulation activity in the absence of analyst coverage or index membership. The first notable addition involves an investor (ID 466) acquiring 284,655 shares, valued at approximately $0.41 million, representing a weight of 0.00072% in their portfolio. This position was detected on August 6, 2026, and reflects a modest but distinct entry into the company’s equity structure. A second notable addition was made by another investor (ID 471), who purchased 183,325 shares valued at roughly $0.27 million, accounting for 0.00165% of their holdings. This transaction was detected earlier, on June 20, 2026, further indicating sequential interest from distinct capital sources during the second quarter of 2026. With zero officers, analysts, or index memberships currently associated with HIT, these holder changes represent the primary observable market activity. The company maintains 12 top holders in total, suggesting that while institutional interest is emerging, the shareholder base remains concentrated and the stock lacks broad market visibility or professional research coverage.

Revenue $8.8M; Net margin -18.1%.

• ▍Revenue $8.8M
• ▍Net margin -18.1%

Revenue $25.8M; Net margin 6.1%.

• ▍Revenue $25.8M
• ▍Net margin 6.1%

Revenue $17.3M; Net margin 6.5%.

• ▍Revenue $17.3M
• ▍Net margin 6.5%

Revenue $33.3M; Net margin 3.8%.

• ▍Revenue $33.3M
• ▍Net margin 3.8%

Revenue $19.5M.

• ▍Revenue $19.5M

Revenue $19.5M; Net margin 3.4%.

• ▍Revenue $19.5M
• ▍Net margin 3.4%

Revenue $19.2M.

• ▍Revenue $19.2M